Metastatic Breast Cancer
Conference Coverage
New study backs up capecitabine dosing practice in metastatic BC
Study finds similar progression-free and overall survival in 7-day-on/7-day-off schedule, with fewer side effects than 14 days on, 7 days off.
Latest News
In TNBC, repeated biopsies may reveal emergent HER2-low expression
Results could broaden eligibility for treatment with the antibody-drug conjugate trastuzumab deruxtecan.
Feature
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
Conference Coverage
Ribociclib forestalls recurrence also in early breast cancer
New results come from an interim analysis of a phase 3 randomized trial comparing maintenance therapy with ribociclib plus endocrine therapy with...
From the Journals
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
From the Journals
Outpatient costs top drug costs in some insured, working women with breast cancer
‘Women think they are insured until they get a diagnosis,’ says the author of a new paper.
From the Journals
Survival improved for some patients with metastatic cancers
Among patients with metastatic gastrointestinal stromal tumors, neuroendocrine tumors, melanoma, and several cancers, 5-year survival increased by...
Latest News
Few women identify breast density as a breast cancer risk
FDA requires that women be notified in writing when mammograms identify dense tissue.
Conference Coverage
Use of diagnostic mammograms is inconsistent, survey finds
Many employ diagnostic mammograms for posttreatment surveillance, but benefit is unknown.